Volume 46, Issue 3, Pages (September 2004)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Volume 68, Issue 6, Pages (December 2015)
Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,
Volume 62, Issue 3, Pages (September 2012)
The PSA Era is not Over for Prostate Cancer
Oncological outcomes of high risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy.
Volume 62, Issue 2, Pages (August 2012)
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 2, Pages (August 2010)
Volume 44, Issue 6, Pages (December 2003)
Volume 58, Issue 4, Pages (October 2010)
Volume 4, Issue 5, Pages (September 2017)
Volume 58, Issue 5, Pages (November 2010)
Prostate Cancer: Highlights from 2006
Volume 49, Issue 2, Pages (February 2006)
Volume 74, Issue 2, Pages (August 2018)
Volume 53, Issue 5, Pages (May 2008)
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 68, Issue 3, Pages (September 2015)
Volume 51, Issue 4, Pages (April 2007)
Volume 70, Issue 2, Pages (August 2016)
Prostate Cancer Epidemic in Sight?
Volume 52, Issue 4, Pages (October 2007)
Volume 59, Issue 2, Pages (February 2011)
Volume 63, Issue 4, Pages e53-e56 (April 2013)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 54, Issue 4, Pages (October 2008)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 53, Issue 4, Pages (April 2008)
Volume 70, Issue 3, Pages (September 2016)
Volume 62, Issue 2, Pages (August 2012)
Volume 54, Issue 5, Pages (November 2008)
Volume 68, Issue 3, Pages (September 2015)
Volume 67, Issue 3, Pages (March 2015)
Volume 56, Issue 2, Pages (August 2009)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 64, Issue 6, Pages (December 2013)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 5, Pages (November 2017)
Volume 53, Issue 2, Pages (February 2008)
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Volume 61, Issue 2, Pages (February 2012)
Volume 58, Issue 1, Pages 1-7 (July 2010)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Volume 70, Issue 2, Pages (August 2016)
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 53, Issue 1, Pages (January 2008)
Volume 49, Issue 4, Pages (April 2006)
Volume 74, Issue 4, Pages (October 2018)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
Volume 53, Issue 5, Pages (May 2008)
Volume 54, Issue 2, Pages (August 2008)
Volume 54, Issue 1, Pages (July 2008)
Volume 53, Issue 2, Pages (February 2008)
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 46, Issue 3, Pages 321-326 (September 2004) Residual Benign Prostatic Glands at the Urethrovesical Anastomosis after Radical Retropubic Prostatectomy: Prediction and Impact on Disease Outcome  Roger Paul, Mathias Hoppmann, Heiner van Randenborgh, Hubert Kübler, Michael Alschibaja, Markus Günther, Rudolf Hartung  European Urology  Volume 46, Issue 3, Pages 321-326 (September 2004) DOI: 10.1016/j.eururo.2004.04.023

Fig. 1 Kaplan–Meier analysis and Log-rank test for patients with (B+) and without (B0) benign prostatic glands at the urethrovesical anastomosis demonstrating no differences in PSA-free survival (A) in all patients, (B) in patients with organ-confined prostate cancer (≤pT2b) only and (C) in patients with negative surgical margins (R0) only. European Urology 2004 46, 321-326DOI: (10.1016/j.eururo.2004.04.023)

Fig. 2 Kaplan–Meier analysis and Log-rank test for patients with isolated (B1) or abundant benign prostatic glands (B2) compared to patients without glands (B0) at the urethrovesical anastomosis demonstrating (A) no difference in PSA-free survival and, (B + C) local recurrence free survival. European Urology 2004 46, 321-326DOI: (10.1016/j.eururo.2004.04.023)